BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Fernández C, Navarro-Martin A, Bobo A, Cabrera-Rodriguez J, Calvo P, Chicas-Sett R, Luna J, Rodríguez de Dios N, Couñago F. Single-fraction stereotactic ablative body radiation therapy for primary and metastasic lung tumor: A new paradigm? World J Clin Oncol 2022; 13(2): 101-115 [PMID: 35316929 DOI: 10.5306/wjco.v13.i2.101]
URL: https://www.wjgnet.com/2218-4333/full/v13/i2/101.htm
Number Citing Articles
1
Asmaa M. Ali, Jason B. Greenwood, Mohammad Varasteh, Sergio Esteve, Prakash Jeevanandam, Fabian Göpfert, Denise M. Irvine, Alan R. Hounsell, Conor K. McGarry. Analysis of the interplay effect in lung stereotactic ablative radiation therapy based on both breathing motion and plan characteristics. Journal of Radiotherapy in Practice 2023; 22 doi: 10.1017/S146039692300033X
2
William Donahue, Shu Xing, Lauren Smith, Paola Godoy Scripes, Eric Aliotta, Jim Mechalakos, Lakshmi Santanam, Neelam Tyagi, Seng Boh Lim. Characterizing the motion management system accuracy on a 1.5T MR-Linac. Physica Medica 2025; 139 doi: 10.1016/j.ejmp.2025.105189
3
Francesco Cuccia, Gianluca Mortellaro, Marina Campione, Vanessa Figlia, Antonio Spera, Daniela Cespuglio, Salvatore D’Alessandro, Claudio Napoli, Francesco Azzarello, Francesco Verderame, Giuseppe Failla, Livio Blasi, Giuseppe Carruba, Giuseppe Ferrera. Single-fraction stereotactic radiotherapy for lung malignancies: preliminary results of a mono-institutional experience. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1933254
4
Ryma Haroun, Cleopatra Rutihinda, Aissatou Hadja Diallo, Juan Pablo Ordonez, Sahar Nassri, Aliya Shams, Maria Fernanda Meza Pacheco, Nour Elhouda Saidi, Lea Bouchard, Guy-Anne Turgeon, Denis Gris, Lee-Hwa Tai, Ayman J. Oweida. Toll-like receptor 4 inhibition sensitizes non-small cell lung cancer to radiotherapy. Cancer Biology & Therapy 2025; 26(1) doi: 10.1080/15384047.2025.2590881
5
Austin J. Iovoli, Sharan Prasad, Sung Jun Ma, Fatemeh Fekrmandi, Nadia K. Malik, Simon Fung-Kee-Fung, Mark K. Farrugia, Anurag K. Singh. Long-Term Survival and Failure Outcomes of Single-Fraction Stereotactic Body Radiation Therapy in Early Stage NSCLC. JTO Clinical and Research Reports 2023; 4(12) doi: 10.1016/j.jtocrr.2023.100598
6
Alex Burton, Mathieu Gaudreault, Nicholas Hardcastle, Jessica Lye, Sabeena Beveridge, Stephen F. Kry, Rick Franich. Optimized scoring of end-to-end dosimetry audits for passive motion management – A simulation study using the IROC thorax phantom. Physica Medica 2024; 121 doi: 10.1016/j.ejmp.2024.103363
7
Phillip D.H. Wall, Laura Cella, Guillaume Landry, Hania Al-Hallaq. The State of Tomorrow’s SBRT. International Journal of Radiation Oncology*Biology*Physics 2026; 124(5) doi: 10.1016/j.ijrobp.2025.11.031
8
Francesco Cuccia, Ciro Franzese, Suraiya Dubash, Valeria Dionisi, Thomas Brunner, Francesco Cellini, Juliane Hörner-Rieber, Thomas Zilli, Bartłomiej Tomasik, Dirk Verellen, Stephanie Tanadini-Lang, Marta Scorsetti. Efficacy and safety of single-fraction stereotactic body radiotherapy (SBRT) for the curative treatment of extracranial primary Tumors: A collaborative systematic review on behalf of the SBRT Focus Group of the European Society for Radiotherapy & Oncology (ESTRO). Clinical and Translational Radiation Oncology 2027; 62 doi: 10.1016/j.ctro.2026.101295